Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

NCT02877771 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.

NCT NCT02877771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02877771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
Lead sponsor
Tandem Diabetes Care, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2016
Completion date
August 31, 2016
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin pump, type 1 diabetes